Odey Asset Management Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Odey Asset Management Group’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-18,898	Closed	-$2.48M	–	65
2019 Q2	$2.48M	Hold	18,898	–	–	0.21%	44
2019 Q1	$2.56M	Hold	18,898	–	–	0.21%	40
2018 Q4	$1.84M	Hold	18,898	–	–	0.16%	49
2018 Q3	$2.63M	Hold	18,898	–	–	0.22%	40
2018 Q2	$2.35M	Hold	18,898	–	–	0.22%	38
2018 Q1	$2.11M	Hold	18,898	–	–	0.23%	37
2017 Q4	$2.26M	Sell	18,898 -1,379	-7%	-$168K	0.21%	37
2017 Q3	$2.85M	Hold	20,277	–	–	0.26%	42
2017 Q2	$2.47M	Buy	+20,277	New	+$2.36M	0.27%	39
2016 Q4	–	Sell	-10,500	Closed	-$1.29M	–	85
2016 Q3	$1.29M	Buy	+10,500	New	+$1.35M	0.09%	58

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Odey Asset Management Group's ALXN Position: Q3 2019 in Review

Odey Asset Management Group sold out of Alexion Pharmaceuticals (ALXN) in Q3 2019, closing a stake of 18,898 shares — an estimated $2.48M sold.

Odey Asset Management Group first reported a position in ALXN in Q3 2016 and held it in 10 quarters. The position peaked at $2.85M in Q3 2017. 646 funds tracked by Wall St. Rank hold ALXN as of Q3 2019.

Odey Asset Management Group reported no remaining Alexion Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Odey Asset Management Group sold 18,898 Alexion Pharmaceuticals shares in Q3 2019, an estimated $2.48M.
Odey Asset Management Group first reported a position in Alexion Pharmaceuticals in Q3 2016 and held it in 10 quarters.
Odey Asset Management Group's Alexion Pharmaceuticals position peaked at $2.85M in Q3 2017.
646 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2019.

Based on Odey Asset Management Group's 13F filing for Q3 2019, filed 14 Nov 2019.